Life Science Real Estate Occupancy Bottomed in 2025
After 16 consecutive quarters of declining occupancy, the free fall in life science real estate appears to be over. 4Q25 marked an important turning point, with U.S. occupancy bottoming and …
BioScience Demand
A Market to Watch: DC–Baltimore Finds Its Footing
While many life science cluster markets continue to struggle with the effects of elevated deliveries and softer demand, several are beginning to show signs of stabilization. The DC–Baltimore cluster is …
Life Science Sublease Availability Climbs 12% in 1Q26
Direct vacancy in life-science real estate has begun to stabilize over the past several quarters, but sublease availability continues to rise. Rising sublease space signals potential tenant turnover and underscores …
Some Markets are Recovering – Elsewhere Vacancy Continue to Climb
After the wave of speculative life science construction in recent years, all eyes are on fundamentals to see when meaningful recovery will occur. While overall there is no confirmation that …
Raleigh-Durham Set for Major Expansion
U.S. life science manufacturing has had strong tailwinds for more than five years, starting with pandemic-related supply chain disruptions and continuing with the recent policy changes that encourage onshoring. The …
San Francisco Bay Area Faces Ongoing Market Challenges
While several U.S. life science markets have begun to stabilize or show early signs of recovery, San Francisco/San Jose remains in a period of adjustment as new supply continues to …
Life Science Construction Picks Up in 2Q
At the end of 2024, construction starts for life science projects had slowed to the lowest point since the onset of the pandemic, with less than 1 million square feet …
A Look at the Worcester, MA Life Science Real Estate Market
he Worcester Life Science market lies in Central Massachusetts (MA) and serves as a natural growth point for life science companies looking to grow from the Boston/Cambridge CBSA.
Newer Life Science Properties Driving Occupancy Losses Across the Sector
The US Life Science or Biotech real estate sector has seen tremendous growth during the past 3 years. Overall, since 2Q22, the US Life Science sector has grown by 17% to 401 million square feet (MSF) in 2Q25.
Oversupply Presents Opportunity for Established Pharma
With many state-of-the-art, brand-new research facilities sitting empty across major research clusters in the U.S., established pharmaceutical and biotechnology firms have an opportunity to secure ideal spaces in prime locations. …
New Deliveries, Older Properties Most Impacted by Oversupply
Last year Life Science inventory in the top 3 clusters, Boston, San Francisco & San Diego, grew by over 10%. With this incredible growth, combined with softer space demand, many …
Established Micro Clusters More Insulated from Market Cycles
With a significant amount of new inventory entering the market and weaker demand for space due to the volatile funding environment, the top three life science real estate markets—Boston, San …
Life Science Real Estate Fundamentals Showing Signs of Stabilizing
The chart below shows aggregate LSRE trends in the top 3 markets from 2Q22 to 4Q24. It represents almost 150 million square feet tracked by RevistaLab.com in these 3 markets.
4Q Life Science Inventory Reaches 400 Million Square Feet
The Life Science real estate sector is closing out 2024 with a total of 21.2M square feet of project completions, pushing sector inventory over 400M square feet. This represents an …
Life Science Occupancy Flattens in 3Q
The spotlight continues to be on the Life Science real estate sector as the industry works to absorb the significant amount of new inventory coming online. Nationwide, 23 million square …
Life Science Cluster Performance Varies Widely
Revista tracks life science properties across the entire U.S. and virtually every area has felt an impact from reduced space demand combined with overbuilding. That being said, not every life …
LSRE – Demand is Growing but not as fast as Supply
For those tracking the Life Science Real Estate Sector (LSRE) it should be no surprise that supply is growing currently.
Here are 4 large Life Science Markets with Current Occupancy Above 90%
In fact, the overall US occupancy rate is currently 89.7% as of 2Q24 and is down 320 basis points from 2Q23. The occupancy rate declines have been largely supply driven as the overall US inventory has grown by over 6% during the past year.